Description
Product Overview
PT-141 (Bremelanotide) is a synthetic heptapeptide supplied by PeptaCo for qualified laboratory research. It is a melanocortin receptor agonist designed for research into sexual function and arousal pathways. PT-141 is widely referenced in neuroscience and peptide biology investigations.
Key Product Details
- Product Name: PT-141 (Bremelanotide)
- Specification: 10mg per vial
- Product Form: Lyophilized powder
- Category: Neuro Research Peptides
- Peptide Sequence: Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-OH (cyclic heptapeptide)
Chemical Identity
PT-141 is a cyclic heptapeptide analog of α-MSH (melanocyte-stimulating hormone). Molecular Formula: C₄₃H₅₇N₁₁O₇. Molecular Weight: ~831 Da. PubChem CID: 5311118. The cyclic structure enhances receptor binding affinity compared to linear α-MSH fragments.
Research Context
PT-141 is extensively studied in neuroscience research for its effects on melanocortin receptors MC3-R and MC4-R. It is commonly referenced in investigations of sexual arousal pathways, dopamine modulation, and peptide-mediated behavioral responses. PeptaCo supplies PT-141 in high-purity format for qualified laboratory customers.
Storage and Handling
Store in a cool, dry place away from direct light. Follow batch-specific storage instructions provided with the certificate of analysis. Avoid repeated freeze-thaw cycles. Handle using standard laboratory practices.
Documentation and Quality
Batch-specific analytical documentation is available to qualified customers upon request. Contact PeptaCo with the product SKU and required quantity to request the current documentation package, which may include identity confirmation, purity analysis, and batch traceability records.
Important Notice
This product is supplied for qualified laboratory research and analytical applications only. It is not for human or veterinary use. Product specifications may vary by batch. Appearance, analytical results, counter-ion information, and other release specifications should be confirmed against the certificate issued for the current batch.
Reviews
There are no reviews yet.